A Bayesian model of dose-response for cancer drug studies
From MaRDI portal
Publication:2154172
Abstract: Exploratory cancer drug studies test multiple tumor cell lines against multiple candidate drugs. The goal in each paired (cell line, drug) experiment is to map out the dose-response curve of the cell line as the dose level of the drug increases. We propose Bayesian Tensor Filtering (BTF), a hierarchical Bayesian model for dose-response modeling in multi-sample, multi-treatment cancer drug studies. BTF uses low-dimensional embeddings to share statistical strength between similar drugs and similar cell lines. Structured shrinkage priors in BTF encourage smoothness in the dose-response curves while remaining adaptive to sharp jumps when the data call for it. We focus on a pair of cancer drug studies exhibiting a particular pathology in their experimental design, leading us to a non-conjugate monotone mixture-of-Gammas likelihood. To perform posterior inference, we develop a variant of the elliptical slice sampling algorithm for sampling from linearly-constrained multivariate normal priors with non-conjugate likelihoods. In benchmarks, BTF outperforms state-of-the-art methods for covariance regression and dynamic Poisson matrix factorization. On the two cancer drug studies, BTF outperforms the current standard approach in biology and reveals potential new biomarkers of drug sensitivity in cancer. Code is available at https://github.com/tansey/functionalmf.
Recommendations
- A Bayesian Approach to Dose-Response Assessment and Synergy and Its Application to In Vitro Dose-Response Studies
- BMA‐Mod: A Bayesian model averaging strategy for determining dose‐response relationships in the presence of model uncertainty
- Bayesian Analysis for Linearized Multi-Stage Models in Quantal Bioassay
- A hierarchical Bayesian design for phase I trials of novel combinations of cancer therapeutic agents
- Bayesian Nonparametric Inference on the Dose Level with Specified Response Rate
Cites work
- $\ell_1$ Trend Filtering
- A Bayesian approach to non-parametric monotone function estimation
- A Bayesian regression tree approach to identify the effect of nanoparticles' properties on toxicity profiles
- Adaptive piecewise polynomial estimation via trend filtering
- Adjusting batch effects in microarray expression data using empirical Bayes methods
- Bayesian Inference for Logistic Models Using Pólya–Gamma Latent Variables
- Bayesian Isotonic Regression and Trend Analysis
- Bayesian Multivariate Isotonic Regression Splines
- Bayesian Nonparametric Estimation of Continuous Monotone Functions with Applications to Dose–Response Analysis
- Bayesian additive adaptive basis tensor product models for modeling high dimensional surfaces: an application to high‐throughput toxicity testing
- Bayesian joint modeling of chemical structure and dose response curves
- Bayesian monotone regression using Gaussian process projection
- Bayesian nonparametric covariance regression
- Bayesian nonparametric modeling using mixtures of triangular distributions
- Deviance information criteria for missing data models
- Dynamic shrinkage processes
- Hierarchical dose-response modeling for high-throughput toxicity screening of environmental chemicals
- Locally adaptive smoothing with Markov random fields and shrinkage priors
- On the second-order random walk model for irregular locations
- Pattern recognition and machine learning.
- Penalized regression, standard errors, and Bayesian Lassos
- Slice sampling. (With discussions and rejoinder)
- The horseshoe estimator for sparse signals
- The horseshoe estimator: posterior concentration around nearly black vectors
- The horseshoe+ estimator of ultra-sparse signals
- Toxicity profiling of engineered nanomaterials via multivariate dose-response surface modeling
Cited in
(8)- Bayesian joint modeling of chemical structure and dose response curves
- DICE: A Bayesian model for early dose finding in phase I trials with multiple treatment courses
- BMA‐Mod: A Bayesian model averaging strategy for determining dose‐response relationships in the presence of model uncertainty
- Bayesian dose regimen assessment in early phase oncology incorporating pharmacokinetics and pharmacodynamics
- functionalmf
- Bayesian Methods for a Three-State Model for Rodent Carcinogenicity Studies
- Bayesian modelling of a pharmaceutical experiment with heterogeneous responses
- A Bayesian Approach to Dose-Response Assessment and Synergy and Its Application to In Vitro Dose-Response Studies
This page was built for publication: A Bayesian model of dose-response for cancer drug studies
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2154172)
